Wayel Kaakaji
Spinal and Neurosurgical Institute
Wayel Kaakaji, MD, is the Chief Executive Officer and Medical Director at the Spinal and Neurosurgical Institute. He has expertise in the management of brain and spine tumors and movement disorder surgery such as deep brain stimulation for Parkinson's disease. Dr. Kaakaji has interest in surgical pain management, spinal cord stimulation, and intrathecal morphine therapy. He has expertise in the treatment of complex spine disease, including spinal fusion, instrumentation, minimally-invasive spine surgery, kyphoplasty, and treatment of osteoporotic compression fractures and of trigeminal neuralgia. Dr. Kaakaji has research interests in brain tumors, brain tumor stereotactic surgery, and vagal nerve stimulation for the treatment of epilepsy. He is a member of the North American Spine Society, American Association of Neurological Surgeons, and Congress of Neurological Surgeons. Dr. Kaakaji has served as a Neurosurgeon at the St. John Hospital and Medical Center. (This is me - Update Profile)
| 2005 - present | Chief Executive Officer and Medical Director Spinal and Neurosurgical Institute |
|---|---|
| 2002 - 2005 | Neurosurgeon Michigan Brain and Spinal Surgery Institute |
| 1999 - 2002 | Neurosurgeon Neurological and Spinal Surgery P.C. |
| 1997 - 1999 | Chief Resident Cleveland Clinic Foundation |
GLG Study Groups with Wayel Kaakaji(?)
| Study Group Name | Members |
|---|---|
| Surgeons who Perform Spinal Fusions | 80 |
| Orthopedic Surgeons (US) | 907 |
| VNS Users for Epilepsy | 28 |
| Orthopedic Surgeons who Perform Kyphoplasty (US) | 62 |
GLG NewsSM Analyses by Wayel Kaakaji(?)
The data presented by multiple professional societies does not lend clinical support of many Medtronic products in the Medicare population. The data does not support the use of disc arthroplasty in the Medicare population, and does not find any clinical advantage of kyphoplasty over vertebroplasty. ...
New electrode will increase the capabilities of the Advance device from Neurometrix, potentially leading to more sales of the disposable electrodes The increased capabilities may also increase the number of practicioners interested in the Advance system, generating more sales for the company
The cost of proton beam installations is massive, and is not justified in light of available litterature regarding the superiority of this therapy. There are only a handful of tumors, such as chordoma, where the proton beam therapy is recommended over other types of radiation. The higher compensation...
Aricept, Namenda, Risperdal are grossly overused in the treatment of patients with suspected dementia Many patients with dementia have not received proper diagnosis, and do not receive proper treatment Better public and medical education will hopefully reverse this glaring deficit in our medical sy...
GLG InstituteSM Seminars with Wayel Kaakaji(?)
Recent Seminars
Request a project with Wayel Kaakaji
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms